- Tips for Spending Holiday Time With Family Members Who Live with Dementia
- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
Underwear That Guards Against STDs During Oral Sex? FDA Says Yes
The first underwear meant to protect against sexually transmitted infections during oral sex was approved by the U.S. Food and Drug Administration on Thursday.
Lorals — which are available as bikinis or shorties — are made of vanilla-flavored latex about as thin as condom material and form a seal on the inside of the thigh to keep fluids in, developer Melanie Cristol told the New York Times. They are to be used only once, like a condom.
On Thursday, Cristol’s company will begin selling the underwear explicitly for infection protection.
Infections such as herpes, gonorrhea and syphilis can be transmitted through oral sex, according to the U.S. Centers for Disease Control and Prevention.
Until now, the only FDA- authorized product for protection during oral sex was a dental dam, a thin sheet of latex polyurethane typically held in place with hands to form a barrier between the mouth and genitals, according to the Times.
“The FDA’s authorization of this product gives people another option to protect against STIs during oral sex,” Courtney Lias, director of the FDA office that led the review of the underwear, told the Times.
“Oral sex is not totally risk-free,” Dr. Jeanne Marrazzo, director of the division of infectious diseases at the University of Alabama at Birmingham, told the Times.
There’s growing need for such protection because more “teenagers are initiating their first sexual activity with oral sex,” she said.
Offering protection that’s enjoyable to use could “reduce anxiety and increase pleasure around that particular behavior,” for people of all ages, Marrazzo added.
Human clinical trials of Lorals were not needed for the FDA’s approval, but the agency did require documentation about thickness, elasticity, strength and other measures, as it does with condoms, the Times reported.
In the past year, the FDA has also given approval to two new dental dam companies, which may suggest increased consumer interest, according to the newspaper.
More information
Visit the U.S. Centers for Disease Control and Prevention for more on sexually transmitted infections.
SOURCE: New York Times
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.